Bragar Eagel & Squire, P.C. Reminds Investors of Novo, Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the FirmNEW YORK, Aug. 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Novo Nordisk A/S (
NYSE:NVO), Altimmune, Inc. (
NASDAQ:ALT), SelectQuote, Inc. (
NYSE:SLQT) and Spectrum Pharmaceuticals, Inc. (
NASDAQ:SPPI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Kaplan Fox Reminds SelectQuote, Inc. (SLQT) Investors of a Securities Class Action Deadline on October 10, 2025Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox Reminds SelectQuote, Inc. (SLQT) Investors of a Securities Class Action Deadline on October 10, 2025NEW YORK, NY - August 30, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT) on behalf of investors that purchased or otherwise acquired SelectQuote securities between September 9, 2020 and May 1, 2025 (the “Class Period”).
Faruqi & Faruqi Reminds SelectQuote Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 10, 2025 – SLQTFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In SelectQuote To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in SelectQuote, Inc. of Class Action Lawsuit and Upcoming Deadlines - SLQTNEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Kirby McInerney LLP Reminds SelectQuote, Inc. Investors of Class Action Filing and Encourages Investors to Contact the FirmNEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE:SLQT) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
Kaplan Fox Encourages Investors of SelectQuote, Inc. (SLQT) to Contact the Firm Before Lead Plaintiff Deadline on October 10, 2025NEW YORK, NY - August 28, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT) on behalf of investors that purchased or otherwise acquired SelectQuote securities between September 9, 2020 and May 1, 2025 (the “Class Period”).
Kaplan Fox Encourages Investors of SelectQuote, Inc. (SLQT) to Contact the Firm Before Lead Plaintiff Deadline on October 10, 2025Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
SELECTQUOTE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against SelectQuote, Inc. - SLQTNEW ORLEANS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT), if they purchased the Company’s securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
SELECTQUOTE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against SelectQuote, Inc. - SLQTNEW YORK and NEW ORLEANS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT), if they purchased the Company’s securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
Kaplan Fox Alerts Investors to a Securities Class Action Against SelectQuote, Inc. (SLQT) - Deadline is October 10, 2025Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox Alerts Investors to a Securities Class Action Against SelectQuote, Inc. (SLQT) - Deadline is October 10, 2025NEW YORK, NY - August 26, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT) on behalf of investors that purchased or otherwise acquired SelectQuote securities between September 9, 2020 and May 1, 2025 (the “Class Period”).
Lowey Dannenberg Notifies SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the FirmNEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT) for violations of the federal securities laws on behalf of investors who purchased or acquired SelectQuote securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”).
Bragar Eagel & Squire, P.C. Reminds Investors of Novo, Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the FirmNEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Novo Nordisk A/S (
NYSE:NVO), Altimmune, Inc. (
NASDAQ:ALT), SelectQuote, Inc. (
NYSE:SLQT) and Spectrum Pharmaceuticals, Inc. (
NASDAQ:SPPI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in SelectQuote, Inc. of Class Action Lawsuit and Upcoming Deadlines - SLQTNEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against SelectQuote, Inc. (NYSE: SLQT)NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of SelectQuote, Inc. (“SelectQuote” or the “Company”) (
NYSE: SLQT) between September 9, 2020 and May 1, 2025, inclusive.
SLQT Stockholders with Large Losses Should Contact Shareholder Rights Law Firm Robbins LLP for Information About the SelectQuote, Inc. Class ActionSAN DIEGO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired SelectQuote, Inc. (
NYSE: SLQT) securities between September 9, 2020 and May 1, 2025. SelectQuote is an insurance broker which sells Medicare Advantage and other health insurance plans online and by telephone.
Bragar Eagel & Squire, P.C. Reminds Investors of Novo, Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the FirmNEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Novo Nordisk A/S (
NYSE:NVO), Altimmune, Inc. (
NASDAQ:ALT), SelectQuote, Inc. (
NYSE:SLQT) and Spectrum Pharmaceuticals, Inc. (
NASDAQ:SPPI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
CORRECTING and REPLACING SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2025 Results
This press release is to correct and replace the previously issued press release to reflect the following:
